Biohaven (BHVN) had its price target lowered by HC Wainwright from $11.00 to $10.00. They now have a "neutral" rating on the stock.
Biohaven (BHVN) had its "outperform" rating reaffirmed by Leerink Partners.
Biohaven (BHVN) had its price target raised by Royal Bank Of Canada from $22.00 to $23.00. They now have an "outperform" rating on the stock.
Biohaven Non-GAAP EPS of -$0.90 beats by $0.06 [Seeking Alpha]
Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]